EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke

Yuki Takeda, Yoji Kuramoto, Shoichiro Tsuji, Nobutaka Doe, Kenichi Yamahara, Shinichi Yoshimura

Brain Research · 2027-01 · 1895 · 150617

DOI: 10.1016/j.brainres.2026.150617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2027-01. Verfasst von Yuki Takeda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hyogo Medical University, Hyogo 663-8501, Japan. Electronic address: ds23023@hyo-med.ac.jp. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell therapy using human umbilical cord-derived mesenchymal stem cells (hUCMSCs) is attracting attention as a promising treatment strategy for ischemic stroke. This study investigated the therapeutic effects and associated biological changes following hUCMSC administration during the subacute phase using a mouse model of permanent middle cerebral artery occlusion (MCAO). Based on our previous findings showing an increase in CD163-positive brain immune cells after hUCMSC administration, we hypothesized that subacute hUCMSC treatment would be associated with changes in myeloid immune responses and high-mobility group box 1 (HMGB1) dynamics. hUCMSCs were administered intravenously two weeks after MCAO induction. Ischemic brain and systemic immune responses were evaluated at the 3rd, 4th, and 5th weeks post-MCAO using flow cytometry, RT-qPCR, immunohistochemistry, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL), Evans Blue assay, Western blotting, and ELISA. Neurobehavioral outcomes were also assessed during the subacute and chronic phases after MCAO. Subacute hUCMSC administration was associated with improved neurobehavioral outcomes after ischemic stroke. Brain immune-cell analyses showed treatment-associated changes in CD163/CD204 co-expression and intracellular HMGB1 accumulation, while peripheral myeloid populations also exhibited changes in CD163 expression within Ly6C subsets. These findings indicate that neurobehavioral improvement following hUCMSC administration was accompanied by local and systemic myeloid immune changes and altered intracellular HMGB1 dynamics.

Schlagwörter

Stichwörter der Autor:innen

Brain myeloid cellsHMGB1Human umbilical cord-derived mesenchymal stem cells (hUCMSC)Ischemic strokeNeuroinflammationSubacute phase

Autor:innen und Institutionen

  • Department of Neurosurgery, Hyogo Medical University, Hyogo 663-8501, Japan. Electronic address: ds23023@hyo-med.ac.jp.
  • Department of Neurosurgery, Hyogo Medical University, Hyogo 663-8501, Japan. Electronic address: yo-kuramoto@hyo-med.ac.jp.
  • Department of Neurosurgery, Hyogo Medical University, Hyogo 663-8501, Japan. Electronic address: sh-tsuji@hyo-med.ac.jp.
  • Laboratory of Neurogenesis and CNS Repair, Hyogo Medical University, Hyogo 663-8501, Japan; Laboratory of Psychology, Faculty of Rehabilitation, Hyogo Medical University, Hyogo 650-8530, Japan. Electronic address: doe@h…
  • Laboratory of Medical Innovation, Institute for Advanced Medical Sciences, Hyogo Medical University, Hyogo 663-8501, Japan. Electronic address: yamahara@hyo-med.ac.jp.
  • Department of Neurosurgery, Hyogo Medical University, Hyogo 663-8501, Japan. Electronic address: hyogoneuro@yahoo.co.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Takeda, Y., Kuramoto, Y., Tsuji, S., Doe, N., Yamahara, K., & Yoshimura, S. (2027). Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke. Brain Research, 1895, 150617. https://doi.org/10.1016/j.brainres.2026.150617

Vancouver

Takeda Y, Kuramoto Y, Tsuji S, Doe N, Yamahara K, Yoshimura S. Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke. Brain Research. 2027;1895:150617. doi:10.1016/j.brainres.2026.150617

BibTeX
@article{Takeda2027,
  author = {Takeda, Yuki and Kuramoto, Yoji and Tsuji, Shoichiro and Doe, Nobutaka and Yamahara, Kenichi and Yoshimura, Shinichi},
  title = {Subacute administration of human umbilical cord-derived mesenchymal stem cells is associated with neurobehavioral improvement, myeloid immune modulation, and altered HMGB1 dynamics after experimental ischemic stroke},
  journal = {Brain Research},
  year = {2027},
  volume = {1895},
  pages = {150617},
  doi = {10.1016/j.brainres.2026.150617}
}
Kostenlos starten →